Jade Biosciences Cash Flow Statement (2020-2026) | JBIO

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M-55.77M
Depreciation and Depletion (Quarter)
0.00M0.01M0.01M0.02M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.22M0.01M0.00M0.00M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.84M0.85M1.02M1.22M1.50M4.71M2.38M3.03M3.24M3.25M4.20M3.87M0.03M1.26M2.42M3.90M4.29M9.40M7.41M13.61M
Cash from Operations (Quarter)
-6.53M-13.09M-5.66M-8.88M-9.72M-14.87M-11.42M-14.94M-15.61M-14.80M-23.67M-6.80M-22.61M-18.76M-20.16M-22.12M-33.66M-24.10M-43.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.03M-0.06M-0.29M-0.59M-0.67M-0.64M-0.81M-0.94M-0.76M-0.69M-0.46M-0.34M-0.23M0.61M0.49M0.36M
Depreciation & Amortization (CF) (Quarter)
0.00M0.01M0.01M0.02M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.22M0.01M0.00M0.00M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter)
1.09M-1.04M1.59M-0.71M2.24M-1.75M2.12M0.77M-2.01M-1.04M0.83M0.95M0.30M1.29M2.68M2.26M-4.88M0.30M2.33M2.10M
Change in Accured Expenses (Quarter)
-0.03M0.03M0.50M-0.31M1.44M-1.77M0.72M1.84M-2.67M10.11M-3.06M0.59M0.24M3.98M-1.95M4.81M4.58M-3.50M5.77M0.08M
Other Working Capital Changes (Quarter)
2.06M4.73M-2.13M-3.36M1.12M-0.30M-0.64M0.73M0.03M-0.61M2.11M2.65M0.21M0.27M0.51M0.85M0.41M10.20M-5.44M2.83M
Investing Activities
Capital Expenditures (Quarter)
-0.01M-0.01M0.03M0.40M-0.24M1.68M0.03M0.02M0.03M0.03M-0.00M-2.51M1.72M0.23M-0.06M-0.03M0.28M-0.15M
Change in Acquisitions & Divestments (Quarter)
12.52M47.23M30.25M64.75M31.00M36.75M34.75M33.50M23.58M18.00M21.00M13.13M12.85M65.43M44.69M
Cash from Investing Activities (Quarter)
-0.06M-113.34M-20.40M8.19M4.64M14.49M15.38M3.98M-13.13M5.65M8.83M13.13M12.85M-12.99M-148.71M-98.16M-8.47M-97.63M
Financing Activities
Other financing activities (Quarter)
0.17M-0.02M0.22M0.33M-0.33M0.13M0.70M-0.40M-190.16M0.04M1.53M
Cash from Financing Activities (Quarter)
128.31M-0.25M0.04M0.36M0.22M45.29M0.02M0.46M0.47M94.77M92.00M-0.70M191.31M170.16M-0.80M193.52M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
63.68M-0.25M0.31M
Additional items
Exchange Rate Effect (Quarter)
-0.02M-0.01M-0.07M
Change in Cash (Quarter)
121.73M-126.68M-26.06M-0.68M-5.04M-0.02M4.17M34.33M-28.72M-8.69M-14.37M87.97M69.39M-19.46M171.01M-170.84M38.33M-33.35M52.16M
Free Cash Flow (Quarter)
-6.52M-13.08M-5.69M-9.28M-9.48M-16.55M-11.45M-14.96M-15.64M-14.83M-23.67M2.51M-8.52M-22.84M-18.70M-20.13M-22.41M-33.51M-24.10M-43.64M
Net Cash Flow (Quarter)
121.73M-126.68M-26.06M-0.68M-5.04M-0.02M4.17M34.33M-28.72M-8.69M-14.37M87.97M82.52M-6.61M158.16M-170.83M38.34M-33.37M52.25M